| 产品描述: | Plantaricin A is an antimicrobial peptide that can be derived from Lactobacillus plantarum. Plantaricin A has a synergistic effect with Ciprofloxacin. Plantaricin A shows anti-microbial activity. Plantaricin A increases the membrane potential of S. aureus and the level of intracellular ROS. Plantaricin A inhibits the function of the efflux pump by binding it and altering the structure of MepA, NorA, and LmrS. Plantaricin A significantly relieves inflammation, and promotes wound healing. Plantaricin A permeabilizes cancerous rat pituitary cells. |
| 体外研究: |
Plantaricin A (12.5 μg/mL, 12 h) 能增强 Ciprofloxacin (CIP) 和 Trimethoprim 在 ATCC 29213 中的活性,有效抑制亚致死浓度下金黄色葡萄球菌的生长。 Plantaricin A (12.5 μg/mL, 2 h) 提高金黄色葡萄球菌的膜电位和细胞内活性氧水平。
Plantaricin A (12.5 μg/mL) 通过抑制金黄色葡萄球菌的外排泵功能,与环丙沙星发挥协同作用。
Plantaricin A (1-50 μM, 60 min) 以剂量依赖方式诱导癌变淋巴细胞 Reh、Jurkat 细胞及正常 B、T 细胞死亡。 Plantaricin A (20-50 μM, 50 s) 诱导 PC12 细胞快速膜通透化,导致膜破裂或细胞裂解。 |
| 保存条件: |
-20°C, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0.335 ml |
1.675 ml |
3.349 ml |
| 5 mM |
0.067 ml |
0.335 ml |
0.67 ml |
| 10 mM |
0.033 ml |
0.167 ml |
0.335 ml |
| 50 mM |
0.007 ml |
0.033 ml |
0.067 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |